Recovery in the fourth quarter – Infection prevention key in future healthcare Fourth quarter (October-December 2020) Revenues amounted to SEK 55.6 (59.8) million, a decrease by 7% (adjusted for currency -2%). EBITDA amounted to SEK 4.9 (12.2) million with an EBITDA-margin of 9% (20%). Operating profit amounted to SEK -6.4 (1.7) million. Net...
The Nomination Committee of Bactiguard Holding AB (publ) has today held a meeting and decided to propose Thomas von Koch as new Chairman of the Board at the Annual General Meeting on April 28, 2021. The current Chairman of the Board, Christian Kinch, is proposed by the Nomination Committee as new Deputy Chairman of the Board. Cecilia Edström has...
Cecilia Edström has today informed the Board that she wishes to resign as CEO of Bactiguard Holding AB (publ) after seven years in the Executive Management team. The Board will therefore initiate the recruitment of a new CEO. Cecilia Edström will continue in her role as CEO until her successor has been appointed and is available for re-election...
Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing.“I am very pleased that the CE mark has been secured for Bactiguard-coated Zimmer Biomet trauma implants. This clearance will pave the way for...
